Adhera Therapeutics Inc.
Ticker Symbol: USOTC:ATRX
OTC Market Tier: OTCQB
CIK Number: 0000737207
Security Type: Common Stock
ATRX Address: 4721 Emperor Boulevard
Suite 350
Durham, North Carolina 27703
ATRX Country: USA
ATRX Phone: 919-578-5901
ATRX Fax #: N/A
Website: http://www.adherathera.com
Description: Adhera Therapeutics, Inc. is an emerging specialty pharmaceutical company leveraging innovative distribution models and technologies to improve the quality of care for patients in the United States suffering from chronic and acute diseases. We are focused on fixed dose combination ("FDC") therapies in hypertension, with plans to expand the portfolio of drugs we commercialize to include other therapeutic areas. We began marketing Prestalia, a single-pill FDC of perindopril arginine inhibitor and amlodipine besylate, which was approved by the U.S. Food and Drug Administration in June of 2018. Prestalia is distributed through the DyrectAxess platform which we acquired in 2017. DyrectAxess is a patented technology platform, also known as Total Care, that offers enhanced efficiency, control and information to empower patients, physicians and manufacturers to achieve optimal care. By combining Prestalia, DyrectAxess, and a specialty pharma network, we have created a proprietary platform for drug adherence and the effective treatment of hypertension, improving the distribution of FDC hypertensive drugs, such as Prestalia, devices for therapeutic drug monitoring, as well as patient counseling and prescription reminder services.
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized: 180,000,000
Shares Outstanding: 10,869,530
Shares Outstanding Date: 07/26/2019
Shares Holder Count: 50
Shares Holder Date: 04/16/2019
Market Capitalization: $ 1,956,515.40
Key Executives: Michael Campoli - Securities Counsel
Erik Emerson - Dir.
Uli Hacksell - Chairman
Tim Boris - Dir.
Donald Williams - Dir.
Nancy Phelan - Dir.
Isaac Blech - Dir.
Number of Employees: 24
Incorporation State: DE
Incorporation Country: USA
Incorporation Year: 1983
Auditor: Squar, Milner, Peterson, Miranda & Williamson, LLP
Auditor Address: 4100 Newport Place Drive
Newport Beach, CA 92660
United States
Auditor Website: N/A
IR Firm: N/A
Legal Counsel: Pryor Cashman LLP
Legal Counsel Address: 7 Times Square
New York, NY 10036-6569
USA
Legal Counsel Website: http://www.pryorcashman.com
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: American Stock Transfer & Trust Company
TA Address: 6201 15th Avenue
Brooklyn, NY 11219
USA
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 29,162
Short Date: 05/15/2019
Closing MMID: 8
BFCMmid: 5
Tier ID: 10
Status: Active


Your Recent History
USOTC
ATRX
Adhera The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.